Both in Pharmaceuticals
Eli Lilly & vs ABBVIE
Over the past year LLY returned +63.1% and ABBV returned +19.3%; their daily moves had a correlation of 0.39.
LLY +63.1% ABBV +19.3%Growth of $1, one year, split-adjusted
| Metric | LLY | ABBV |
|---|---|---|
| Price | $1,184.78 | $266.28 |
| Market cap | $1.06T | $470.55B |
| Today | +0.11% | +0.73% |
| 1 month | +0.7% | +3.1% |
| 6 months | +34.9% | +27.2% |
| Year to date | +10.2% | +16.5% |
| 1 year | +65.8% | +21.8% |
| Revenue growth (YoY) | +47.7% | +10.2% |
| Gross margin | 85.8% | 74.7% |
| Net margin | 30.9% | 21.3% |
| P/E (TTM) | 39.5× | 74.8× |
| Price / sales | 13.3× | 7.3× |
| Net cash | -$45.96B | -$64.25B |
| Dividend yield | 0.58% | 2.60% |
| Volatility (60d) | 29.7% | 21.8% |
| Short % of float | 0.9% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).